{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:35:33Z","timestamp":1785522933147,"version":"3.56.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"DOI":"10.1007\/s10557-026-07919-x","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T07:09:47Z","timestamp":1785136187000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early Aspirin Discontinuation After Percutaneous Coronary Intervention in Acute Coronary Syndrome: A Systematic Review and Meta-analysis of Randomized Controlled Trials"],"prefix":"10.1007","author":[{"given":"Hung Phan","family":"Huu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phuong-Uyen","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiaam","family":"Elkhatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuan","family":"Vinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"issue":"38","key":"7919_CR1","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720\u2013826. https:\/\/doi.org\/10.1093\/eurheartj\/ehad191.","journal-title":"Eur Heart J"},{"issue":"13","key":"7919_CR2","doi-asserted-by":"publisher","first-page":"e771","DOI":"10.1161\/CIR.0000000000001309","volume":"151","author":"SV Rao","year":"2025","unstructured":"Rao SV, O\u2019Donoghue ML, Ruel M, et al. 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes. Circulation. 2025;151(13):e771\u2013862. https:\/\/doi.org\/10.1161\/CIR.0000000000001309.","journal-title":"Circulation"},{"issue":"23","key":"7919_CR3","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1161\/CIRCULATIONAHA.116.023751","volume":"134","author":"G Gargiulo","year":"2016","unstructured":"Gargiulo G, Windecker S, Vranckx P, Gibson CM, Mehran R, Valgimigli M. A Critical Appraisal of Aspirin in Secondary Prevention. Circulation. 2016;134(23):1881\u2013906. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.023751.","journal-title":"Circulation"},{"issue":"3","key":"7919_CR4","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1161\/CIR.0000000000001038","volume":"145","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization. Circulation. 2022;145(3):e18\u2013114. https:\/\/doi.org\/10.1161\/CIR.0000000000001038.","journal-title":"Circulation"},{"issue":"4","key":"7919_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1001\/jamacardio.2021.5244","volume":"7","author":"H Watanabe","year":"2022","unstructured":"Watanabe H, Morimoto T, Natsuaki M, et al. Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome: The STOPDAPT-2 ACS Randomized Clinical Trial. JAMA Cardiol. 2022;7(4):407\u201317. https:\/\/doi.org\/10.1001\/jamacardio.2021.5244.","journal-title":"JAMA Cardiol"},{"issue":"8","key":"7919_CR6","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1161\/CIRCULATIONAHA.123.066943","volume":"149","author":"SJ Hong","year":"2024","unstructured":"Hong SJ, Lee SJ, Suh Y, et al. Stopping Aspirin Within 1 Month After Stenting for Ticagrelor Monotherapy in Acute Coronary Syndrome: The T-PASS Randomized Noninferiority Trial. Circulation. 2024;149(8):562\u201373. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.066943.","journal-title":"Circulation"},{"issue":"10456","key":"7919_CR7","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(24)01616-7","volume":"404","author":"M Valgimigli","year":"2024","unstructured":"Valgimigli M, Hong SJ, Gragnano F, et al. De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials. Lancet. 2024;404(10456):937\u201348. https:\/\/doi.org\/10.1016\/S0140-6736(24)01616-7.","journal-title":"Lancet"},{"issue":"7","key":"7919_CR8","doi-asserted-by":"publisher","first-page":"e010247","DOI":"10.1136\/bmjopen-2015-010247","volume":"6","author":"J IntHout","year":"2016","unstructured":"IntHout J, Ioannidis JPA, Rovers MM, Goeman JJ. Plea for routinely presenting prediction intervals in meta-analysis. BMJ Open. 2016;6(7):e010247. https:\/\/doi.org\/10.1136\/bmjopen-2015-010247.","journal-title":"BMJ Open"},{"issue":"7414","key":"7919_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JPT Higgins","year":"2003","unstructured":"Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557\u201360. https:\/\/doi.org\/10.1136\/bmj.327.7414.557.","journal-title":"BMJ"},{"issue":"7109","key":"7919_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334. https:\/\/doi.org\/10.1136\/bmj.315.7109.629.","journal-title":"BMJ"},{"issue":"7650","key":"7919_CR11","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136. https:\/\/doi.org\/10.1136\/bmj.39489.470347.AD.","journal-title":"BMJ"},{"issue":"24","key":"7919_CR12","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1001\/jama.2019.8146","volume":"321","author":"JY Hahn","year":"2019","unstructured":"Hahn JY, Song YB, Oh JH, et al. Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial. JAMA. 2019;321(24):2428\u201337. https:\/\/doi.org\/10.1001\/jama.2019.8146.","journal-title":"JAMA"},{"issue":"23","key":"7919_CR13","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1001\/jama.2020.7580","volume":"323","author":"BK Kim","year":"2020","unstructured":"Kim BK, Hong SJ, Cho YH, et al. Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome: The TICO Randomized Clinical Trial. JAMA. 2020;323(23):2407\u201316. https:\/\/doi.org\/10.1001\/jama.2020.7580.","journal-title":"JAMA"},{"issue":"14","key":"7919_CR14","doi-asserted-by":"publisher","first-page":"e796","DOI":"10.4244\/EIJ-D-24-01049","volume":"21","author":"Y Jang","year":"2025","unstructured":"Jang Y, Park SD, Lee JP, et al. One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial. EuroIntervention. 2025;21(14):e796\u2013809. https:\/\/doi.org\/10.4244\/EIJ-D-24-01049.","journal-title":"EuroIntervention"},{"issue":"21","key":"7919_CR15","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1056\/NEJMoa2412667","volume":"393","author":"PO Guimar\u00e3es","year":"2025","unstructured":"Guimar\u00e3es PO, Franken M, Tavares CAM, et al. Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes. N Engl J Med. 2025;393(21):2095\u2013106. https:\/\/doi.org\/10.1056\/NEJMoa2412667.","journal-title":"N Engl J Med"},{"issue":"10439","key":"7919_CR16","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/S0140-6736(24)00473-6","volume":"403","author":"Z Ge","year":"2024","unstructured":"Ge Z, Kan J, Gao X, et al. Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial. Lancet. 2024;403(10439):1866\u201378. https:\/\/doi.org\/10.1016\/S0140-6736(24)00473-6.","journal-title":"Lancet"},{"issue":"21","key":"7919_CR17","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1056\/NEJMoa1908419","volume":"381","author":"R Mehran","year":"2019","unstructured":"Mehran R, Baber U, Sharma SK, et al. Ticagrelor with or without Aspirin in High-Risk Patients after PCI. N Engl J Med. 2019;381(21):2032\u201342. https:\/\/doi.org\/10.1056\/NEJMoa1908419.","journal-title":"N Engl J Med"},{"issue":"16","key":"7919_CR18","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.jacc.2008.12.055","volume":"53","author":"JW van Werkum","year":"2009","unstructured":"van Werkum JW, Heestermans AA, Zomer AC, et al. Predictors of Coronary Stent Thrombosis: The Dutch Stent Thrombosis Registry. J Am Coll Cardiol. 2009;53(16):1399\u2013409. https:\/\/doi.org\/10.1016\/j.jacc.2008.12.055.","journal-title":"J Am Coll Cardiol"},{"issue":"9562","key":"7919_CR19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","volume":"369","author":"J Daemen","year":"2007","unstructured":"Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet. 2007;369(9562):667\u201378. https:\/\/doi.org\/10.1016\/S0140-6736(07)60314-6.","journal-title":"Lancet"},{"issue":"1","key":"7919_CR20","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4244\/EIJV9I1A10","volume":"9","author":"J Iqbal","year":"2013","unstructured":"Iqbal J, Sumaya W, Tatman V, et al. Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting. EuroIntervention. 2013;9(1):62\u20139. https:\/\/doi.org\/10.4244\/EIJV9I1A10.","journal-title":"EuroIntervention"},{"issue":"9","key":"7919_CR21","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.058560","volume":"125","author":"L R\u00e4ber","year":"2012","unstructured":"R\u00e4ber L, Magro M, Stefanini GG, et al. Very Late Coronary Stent Thrombosis of a Newer-Generation Everolimus-Eluting Stent Compared With Early-Generation Drug-Eluting Stents. Circulation. 2012;125(9):1110\u201321. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.058560.","journal-title":"Circulation"},{"issue":"10151","key":"7919_CR22","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/S0140-6736(18)31858-0","volume":"392","author":"P Vranckx","year":"2018","unstructured":"Vranckx P, Valgimigli M, J\u00fcni P, et al. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. Lancet. 2018;392(10151):940\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(18)31858-0.","journal-title":"Lancet"},{"issue":"24","key":"7919_CR23","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1001\/jama.2019.8133","volume":"321","author":"H Watanabe","year":"2019","unstructured":"Watanabe H, Domei T, Morimoto T, et al. Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial. JAMA. 2019;321(24):2414\u201327. https:\/\/doi.org\/10.1001\/jama.2019.8133.","journal-title":"JAMA"},{"issue":"18","key":"7919_CR24","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMoa2108749","volume":"385","author":"M Valgimigli","year":"2021","unstructured":"Valgimigli M, Frigoli E, Heg D, et al. Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk. N Engl J Med. 2021;385(18):1643\u201355. https:\/\/doi.org\/10.1056\/NEJMoa2108749.","journal-title":"N Engl J Med"},{"issue":"3","key":"7919_CR25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","volume":"140","author":"P Urban","year":"2019","unstructured":"Urban P, Mehran R, Colleran R, et al. Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention. Circulation. 2019;140(3):240\u201361. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.119.040167.","journal-title":"Circulation"},{"issue":"3","key":"7919_CR26","doi-asserted-by":"publisher","first-page":"e1004995","DOI":"10.1371\/journal.pmed.1004995","volume":"23","author":"EP Navarese","year":"2026","unstructured":"Navarese EP, Gurbel P, Tantry U, et al. Early aspirin withdrawal versus dual antiplatelet therapy in high-risk patients after percutaneous coronary intervention: Meta-analysis of randomized trials. PLoS Med. 2026;23(3):e1004995. https:\/\/doi.org\/10.1371\/journal.pmed.1004995.","journal-title":"PLoS Med"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07919-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-026-07919-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07919-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:20:52Z","timestamp":1785518452000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-026-07919-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":26,"alternative-id":["7919"],"URL":"https:\/\/doi.org\/10.1007\/s10557-026-07919-x","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"30 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is a systematic review and meta-analysis of previously published studies. No new data were collected from human participants. Therefore, ethics approval from an institutional review board (IRB) or ethics committee was not required and is not applicable.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study is a systematic review and meta-analysis of existing published literature and did not involve the direct collection of data from human participants. Accordingly, ethics committee approval and consent to participate are not applicable.","order":2,"name":"Ethics","label":"Human Ethics and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All data generated or analyzed during this study are included in this published article and its supplementary materials. Additional data or extraction sheets used in the analysis are available from the corresponding author upon reasonable request.","order":4,"name":"Ethics","label":"Data Access Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"AI assistance was used only for minor editorial tasks, including grammar refinement, phrasing clarification, and formatting alignment with journal style. All scientific decisions, data interpretation, analyses, figures, and tables were performed entirely by the authors. The authors reviewed all AI-assisted text to ensure accuracy and take full responsibility for the integrity and originality of the manuscript contents.","order":5,"name":"Ethics","label":"Statement on Generative Artificial Intelligence Use","group":{"name":"EthicsHeading","label":"Declarations"}}]}}